Penicillin allergy affects more than 25 million people in the United States (up to 1 in 10 Americans) and has been shown to lead to particularly poor health outcomes in pregnant women and surgical patients. It is also a public health threat, leading to antibiotic resistance and infections in hospitalized patients that can be life threatening.
Novartis, Ionis will work together again in the next-generation cardio space
Novartis is once again teaming up with Ionis on a next-generation siRNA cardio drug, picking up another shot in an increasingly competitive space. The deal
August 4, 2023